Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adhesion Scoring Evaluation of Placebo JNJ-35685 Transdermal Systems
NCT02221726Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2014
- Primary completion
- Aug 2014
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Visual Grading United States Food and Drug Administration (FDA) Scale Score at 72 hours, Adhesion Area Calculated by Digital Image Analysis at 72 hours and 1 more. Started Aug 2014; status: completed.
Beyond the preview
Go deeper on NCT02221726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221726.